Osteosarcoma overview: Difference between revisions

Jump to navigation Jump to search
Line 27: Line 27:


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==
Common complications of osteosarcoma include pathologic fracture and [[metastasis]]. The 5-year survival rate of osteosarcoma after adequate therapy is approximately 60-80%. Pretreatment factors that influence outcome of the osteosarcoma are primary tumor site, size of the primary tumor, and site of metastasis. After administration of preoperative chemotherapy, factors that influence outcome of the osteosarcoma are adequacy of tumor resection and [[necrosis]] following induction or [[neoadjuvant chemotherapy]].
Common complications of osteosarcoma include pathologic fracture and [[metastasis]]. Pretreatment factors that influence outcome of the osteosarcoma are primary tumor site, size of the primary tumor, and site of metastasis. After administration of preoperative chemotherapy, factors that influence outcome of the osteosarcoma are adequacy of tumor resection and [[necrosis]] following induction or [[neoadjuvant chemotherapy]]. The 5-year survival rate of osteosarcoma after adequate therapy is approximately 60-80%.


==Diagnosis==
==Diagnosis==

Revision as of 18:34, 30 September 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Osteosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteosarcoma overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteosarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteosarcoma overview

CDC on Osteosarcoma overview

Osteosarcoma overview in the news

Blogs on Osteosarcoma overview

Directions to Hospitals Treating Osteosarcoma

Risk calculators and risk factors for Osteosarcoma overview

Overview

Bone cancer is a malignant (cancerous) tumor of the bone that destroys normal bone tissue. Osteosarcoma is the most common type of malignant bone cancer, accounting for 35% of primary bone malignancies. It is a malignant tumor that is characterized by the direct formation of bone or osteoid tissue by the tumor cells. Malignant tumors that begin in bone tissue are called primary bone cancer. Osteosarcoma may be classified according to the World Health Organization’s histologic classification of bone tumors into three groups. The osteosarcomas may be localized at the end of the long bones (commonly in the metaphysis). Most often it affects the upper end of tibia, humerus, or lower end of femur. On gross pathology, areas of bone formation, hemorrhage, fibrosis, and cystic degeneration on cut surface are characteristic findings of osteosarcoma. On microscopic histopathological analysis, presence of osteoid within the tumor, pleomorphic cells, anaplastic cells, and atypical mitoses are characteristic findings of osteosarcoma. There are no established causes for osteosarcoma. The common risk factors in the development of osteosarcoma are radiation to bones, alkylating antineoplastic agents, Paget disease, multiple hereditary osteochondromas, fibrous dysplasia, Bloom syndrome, Rothmund-Thomson syndrome, and Li-Fraumeni syndrome. Common complications of osteosarcoma include pathologic fracture and metastasis. The most common symptoms of osteosarcoma include bone pain that may be worse at night, swelling, and redness at the site of the tumor. On x-ray, osteosarcoma is characterized by medullary and cortical bone destruction, periosteal reaction, tumor matrix calcification, and soft tissue mass.[1] On MRI, osteosarcoma is characterized by intermediate intensity of soft tissue and low signal intensity of ossified components on T1. High signal intensity of soft tissue and low signal intensity of ossified components on T2. The predominant therapy for osteosarcoma is neoadjuvant chemotherapy (chemotherapy given before surgey) followed by surgical resection. The most common drugs used to treat osteosarcoma are cisplatin, doxorubicin and high-dose methotrexate.

Classification

Osteosarcoma may be classified according to the World Health Organization’s histologic classification of bone tumors into three groups: central (medullary) tumors, surface (peripheral) tumors, and extraskeletal tumors.[2]

Pathophysiology

The osteosarcomas may be localized at the end of the long bones (commonly in the metaphysis). Most often it affects the upper end of tibia, humerus, or lower end of femur. On gross pathology, areas of bone formation, hemorrhage, fibrosis, and cystic degeneration on cut surface are characteristic findings of osteosarcoma. On microscopic histopathological analysis, presence of osteoid within the tumor, pleomorphic cells, anaplastic cells, and atypical mitoses are characteristic findings of osteosarcoma. Osteosarcoma may be associated with hereditary syndromes such as Li-Fraumeni syndrome and Rothmund-Thomson Syndrome.

Causes

There are no established causes for osteosarcoma.

Differential Diagnosis

Osteosarcoma must be differentiated from Ewing's sarcoma, Giant cell tumors, Malignant fibrous histiocytoma, Osteomyelitis, and aneurysmal bone cyst.

Epidemiology and Demographics

Osteosarcoma is the most common type of malignant bone cancer, accounting for 35% of primary bone malignancies. It is the 8th leading cancer in children under age 15, comprising 2.4% of all malignancies in pediatric patients and about 20% of all primary bone cancers. The overall incidence of osteosarcoma in U.S. population under 24 years of age are estimated at 0.44 cases for 100,000 individuals.[3] Osteosarcoma is slightly more common in males than in females. Primary osteosarcoma typically occurs in young patients (10-20 years) with 75% occurring before the age of 20. Secondary osteosarcoma occurs in the elderly patients.

Risk Factors

The common risk factors in the development of osteosarcoma are radiation to bones, alkylating antineoplastic agents, Paget disease, multiple hereditary osteochondromas, fibrous dysplasia, Bloom syndrome, Rothmund-Thomson syndrome, and Li-Fraumeni syndrome.

Screening

Screening for osteosarcoma is not recommended.

Natural History, Complications and Prognosis

Common complications of osteosarcoma include pathologic fracture and metastasis. Pretreatment factors that influence outcome of the osteosarcoma are primary tumor site, size of the primary tumor, and site of metastasis. After administration of preoperative chemotherapy, factors that influence outcome of the osteosarcoma are adequacy of tumor resection and necrosis following induction or neoadjuvant chemotherapy. The 5-year survival rate of osteosarcoma after adequate therapy is approximately 60-80%.

Diagnosis

Staging

According to the American Joint Committee on Cancer (AJCC), there are four stages of osteosarcoma based on the size of primary tumor, metastasis, involvement of lymph nodes, and grade of the tumor. For the purpose of treatment, there are only two stages of high-grade osteosarcoma: localized osteosarcoma and metastatic osteosarcoma.

History and Symptoms

The most common symptoms of osteosarcoma include bone pain that may be worse at night, swelling, and redness at the site of the tumor. The affected bone is not as strong as normal bones and may fracture with minor trauma (a pathological fracture).

Physical Examination

Physical examination findings will depend on the location of the osteosarcoma. Common physical examination findings of osteosarcoma are localized swelling and tenderness.

Laboratory Findings

Laboratory tests for osteosarcoma include complete blood count (CBC), blood chemistry studies such as serum alkaline phosphatase and lactate dehydrogenase.

Biopsy

Biopsy of osteosarcoma is important for confirming the diagnosis and for determining histologic subtype.[4] Biopsy may be performed percutaneously with fine-needle, wide-bore needle, or through a formal incision.

X Ray

On x-ray, osteosarcoma is characterized by medullary and cortical bone destruction, periosteal reaction, tumor matrix calcification and soft tissue mass.[1]

CT

The role of CT scan in osteosarcoma is predominantly in assisting biopsy and staging, but adds little to plain radiography and MRI in direct assessment of the tumor.[5]

MRI

On MRI, osteosarcoma is characterized by intermediate intensity of soft tissue and low signal intensity of ossified components on T1. High signal intensity of soft tissue and low signal intensity of ossified components on T2. Considerable contrast enhancement of solid components on T1 contrast.

Other Imaging Findings

Bone scan in osteosarcoma is used to observe abnormal areas of bone and metastasis.[6]

Other Diagnostic Studies

No additional tests are recommended for the diagnosis of osteosarcoma.

Treatment

Medical Therapy

The predominant therapy for osteosarcoma is neoadjuvant chemotherapy (chemotherapy given before surgey) followed by surgical resection. The most common drugs used to treat osteosarcoma are cisplatin, doxorubicin and high-dose methotrexate. Ifosfamide can be used as an adjuvant treatment if the necrosis rate is low. Samarium is a radioactive drug that targets areas where bone cells growing, such as tumor cells in the bone. It helps relieve pain caused by cancer in the bone.

Surgery

The mainstay of therapy for osteosarcoma is surgical resection. Rather than using the standard staging system, a simpler system is often used when planning treatment for osteosarcoma. This system divides osteosarcomas into 2 groups: localized and metastatic.

References

  1. 1.0 1.1 Osteosarcoma. Dr Amir Rezaee ◉ and Dr Frank Gaillard ◉ et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/osteosarcoma
  2. Osteosarcoma. National cancer institute.http://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq#section/_8
  3. Osteosarcoma. National cancer institute. http://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq
  4. Osteosarcoma. surgwiki. http://www.surgwiki.com/wiki/Diseases_of_bone_and_joints#SURGERY_4
  5. Osteosarcoma. Dr Amir Rezaee ◉ and Dr Frank Gaillard ◉ et al. http://radiopaedia.org/articles/osteosarcoma
  6. Osteosarcoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/bone/diagnosis/?region=bc

Template:WH Template:WS